David A. Siegel Mannkind Corp Put Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MNKD
# of Institutions
210Shares Held
130MCall Options Held
1.81MPut Options Held
808K-
Black Rock Inc. New York, NY21.6MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$76.2 Million0.0% of portfolio
-
State Street Corp Boston, MA11.9MShares$60.1 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$50.7 Million4.85% of portfolio
-
Avoro Capital Advisors LLC New York, NY9MShares$45.3 Million0.49% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.29B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...